Search

Your search keyword '"S100A8"' showing total 1,237 results

Search Constraints

Start Over You searched for: Descriptor "S100A8" Remove constraint Descriptor: "S100A8" Topic s100a8 Remove constraint Topic: s100a8
1,237 results on '"S100A8"'

Search Results

1. SS31 alleviates LPS-induced acute lung injury by inhibiting inflammatory responses through the S100A8/NLRP3/GSDMD signaling pathway.

2. Convenient production of a novel recombinant antibody against periodontitis biomarker S100A8.

3. The role of S100A8 and S100A9 in external auditory canal cholesteatoma.

4. Survival prediction in patients with head and neck squamous cell carcinoma and novel mechanistic insights of S100A8/A9.

5. Intraperitoneal Administration of S100A8 Ameliorates Experimental Acute Colitis in Rats.

6. S100A8 promotes tumor progression by inducing phenotypic polarization of microglia through the TLR4/IL-10 signaling pathway in glioma

7. SS31 alleviates LPS-induced acute lung injury by inhibiting inflammatory responses through the S100A8/NLRP3/GSDMD signaling pathway

8. Survival prediction in patients with head and neck squamous cell carcinoma and novel mechanistic insights of S100A8/A9

9. Suppression of overactivated immunity in the early stage is the key to improve the prognosis in severe burns.

10. Dysregulated S100A9 Expression Impairs Matrix Deposition in Chronic Wounds.

11. Up-Regulation of S100A8 and S100A9 in Pulmonary Immune Response Induced by a Mycoplasma capricolum subsp. capricolum HN-B Strain.

12. Single-Cell RNA Sequencing Reveals Immunomodulatory Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor Treatment in the Brains of Aged APP/PS1 Mice.

13. A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy

14. The role of S100A8 and S100A9 in external auditory canal cholesteatoma

16. Preliminary clinical analysis and pathway study of S100A8 as a biomarker for the diagnosis of acute deep vein thrombosis

17. Blood calprotectin as a biomarker for infection and sepsis – the prospective CASCADE trial

18. Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36.

19. The Natural Product Secoemestrin C Inhibits Colorectal Cancer Stem Cells via p38–S100A8 Feed-Forward Regulatory Loop.

20. Intraperitoneal Administration of S100A8 Ameliorates Experimental Acute Colitis in Rats

23. S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.

24. Eliminating the invading extracellular and intracellular FnBp+ bacteria from respiratory epithelial cells by autophagy mediated through FnBp-Fn-Integrin α5β1 axis.

25. S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1

26. Upregulation of S100A8 in peripheral blood mononuclear cells from patients with depression treated with SSRIs: a pilot study

27. Up-Regulation of S100A8 and S100A9 in Pulmonary Immune Response Induced by a Mycoplasma capricolum subsp. capricolum HN-B Strain

28. Abnormal S100A8 expression associates with postoperative recurrence in chronic rhinosinusitis with nasal polyps

29. Eliminating the invading extracellular and intracellular FnBp+ bacteria from respiratory epithelial cells by autophagy mediated through FnBp-Fn-Integrin α5β1 axis

30. A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection

31. Forkhead box A1 induces angiogenesis through activation of the S100A8/p38 MAPK axis in cutaneous wound healing.

32. S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.

33. Upregulation of S100A8 in peripheral blood mononuclear cells from patients with depression treated with SSRIs: a pilot study.

34. Variation of Plasma Damage-Associated Molecular Patterns in Patients with Advanced Solid Tumors after Standard of Care Systemic Treatment.

35. S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia

36. Expression of S100A8 protein on B cells is associated with disease activity in patients with systemic lupus erythematosus

37. The Natural Product Secoemestrin C Inhibits Colorectal Cancer Stem Cells via p38–S100A8 Feed-Forward Regulatory Loop

38. S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes.

39. S100A8 and S100A9 are associated with endometrial shedding during menstruation.

40. S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy.

41. Identification of S100A8 as a common diagnostic biomarkers and exploring potential pathogenesis for osteoarthritis and metabolic syndrome.

42. Glycyrrhizic acid inhibits myeloid differentiation of hematopoietic stem cells by binding S100 calcium binding protein A8 to improve cognition in aged mice

43. S100A8 enhances IL-1β production from nasal epithelial cells in eosinophilic chronic rhinosinusitis

44. Salmonella pathogenicity island 1 knockdown confers protection against myocardial fibrosis and inflammation in uremic cardiomyopathy via down-regulation of S100 Calcium Binding Protein A8/A9 transcription

45. S100A8 accelerates wound healing by promoting adipose stem cell proliferation and suppressing inflammation

46. S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia.

47. TRPA1 deficiency aggravates dilated cardiomyopathy by promoting S100A8 expression to induce M1 macrophage polarization in rats.

48. Generation of a novel monoclonal antibody against inflammatory biomarker S100A8 using hybridoma technology.

49. Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR -Mutated MPN.

50. Sonoelastography and S100 proteins in the differential diagnosis of IgG4-related disease (IgG4-RD).

Catalog

Books, media, physical & digital resources